Related Experiment Video
Updated: Jul 24, 2025
08:05
Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
14.2K
Lung cancer and COVID-19: problems and perspectives
U Tirelli1, C Cirrito, M Pavanello
1Tirelli Medical Group, Pordenone, Italy. salvatore.chirumbolo@univr.it.
Summary
The COVID-19 pandemic created challenges for lung cancer patients due to overlapping symptoms and lack of clear guidelines. Further research and consensus are needed for managing lung cancer during SARS-CoV-2 infection.
Area of Science:
- Oncology
- Infectious Diseases
- Public Health
Background:
- The COVID-19 pandemic has significantly impacted healthcare systems globally.
- Lung cancer diagnosis and treatment face unique challenges due to overlapping symptoms with COVID-19.
- Italy reports over 27% of cancer cases as lung cancer, highlighting its prevalence.
Purpose of the Study:
- To address the concerns of lung cancer patients co-infected with SARS-CoV-2.
- To review current literature on the interplay between COVID-19 and lung cancer.
- To identify the lack of established protocols for managing lung cancer in SARS-CoV-2 infected patients.
Main Methods:
- Literature review of current evidence and data.
- Analysis of the complex interactions between COVID-19 and cancer, including immune responses.
- Discussion of diagnostic and therapeutic challenges.
Main Results:
- Overlapping clinical presentations of lung cancer and COVID-19 lung injury cause diagnostic confusion.
- Complex immune interactions between SARS-CoV-2 and cancer complicate patient management.
- A significant lack of consensus protocols and expert guidelines for treating lung cancer in COVID-19 patients exists.
Conclusions:
- Urgent need for new insights and consensus panels to guide diagnosis and treatment.
- Prioritization of care between COVID-19 and lung cancer therapy requires clear guidelines.
- Addressing these challenges is crucial for optimizing patient outcomes in oncology during the pandemic.
Related Concept Videos
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
01:17Other Pulmonary Disorders
875
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
875
01:20COPD: Pathogenesis and Clinical Features
358
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
358
01:22Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
01:30Pneumonia III: Complications and Assessment
275
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
275
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K